Roche rapped for Avastin promotion in Brazil
This article was originally published in Scrip
ANVISA, Brazil's medicines agency, has suspended what it describes as promotional material for Roche's Avastin (bevacizumab).
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.